Tableting with high potent active ingredients at Frankfurt Site

Innovative technologies for the development and production of semi-solid and liquid dosage forms are part of our wide range of services in drug development. We will show you the manufacturing of a nanosuspension with subsequent lyophilization under GMP conditions.

The HWI group offers a broad range of individual and specialised pharmaceutical services for the pharma and biotech sector, particularly for active ingredients and medicinal products. Benefit from our long-​standing experience in laboratory services, vigilance and quality services, drug development as well as regulatory affairs services.

Company presentation of HWI group. HWI is a family-owned, independent service partner in the pharma and biotech sector. It stands for quality, flexibility, competence and reliability.

With more than 35 years of experience HWI offers a service portfolio ranging from formulation development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to pre-clinical development, pharmacovigilance and GxP services.

With more than 35 years of experience and our continual quest for improvement, we provide analytical laboratory services of the highest level for active ingredients, excipients, medicinal products and drug-related products. In addition to developing and validating analytical methods, batch release analysis, stability testing and structure determination of unknown substances, our core expertise also includes risk-based and solutions-oriented client consulting.

HWI has been a leading company in drug development for many years. Our experts take innovative therapeutic approaches from conception to market launch. As a CDMO, we also develop and manufacture for our customers on a contract basis. Our services include formulation development  and manufacture as well as analytical method development and characterisation for for solid, semi-solid and liquid medicinal products.

We are an experienced and interdisciplinary team. Based on good pharmacovigilance practice (GVP) recommendations we provide comprehensive and individual support for all pharmacovigilance matters. We support you in conducting GVP audits – fully aligned with current GVP guidelines. This includes, among other things, the planning, conduct, and follow-up of your GVP audits.

The HWI group offers a broad range of individual and specialised pharmaceutical services for the pharma and biotech sector, particularly for active ingredients and medicinal products. Benefit from our long-standing experience in laboratory services, pharmacovigilance, QP services and drug development. 

Our services cover the entire value chain ofmedicinal products with small and large molecules.